NTLA trade ideas
NTLA might be taking a breatherEnded last week with a gravestone looking doji. With dojis on higher timeframes, I like to see a divergence in the lower timeframes that agrees with the reversal. For NTLA we have bearish divergence in the 15m so this doji looks promising. Going to be looking for shorts aiming at ~76.
Inverse head and shoulder pattern. Bullish on this oneAs you can see. NTLA making an inverse head and shoulder pattern which really a beautiful setup. though I would most likely enter once it broke out the $85 price range with a confirmed volume new time high plays. price target for me would be around $150 to $200 with a bullish general market
NTLA Swinging up? 1. Strong uptrend channel, moving from the low area of the channel up. - buy area indicator.
2. SlowStoch buy signal, crossed up from the oversold area + fast line crossing up the slow line - a buy signal.
3. RSI pullback (when moving under 50 and then going up) - a buy signal.
4. MACD is changing the direction of the short trend and going for a buy signal soon.
Note: I noticed that if you wait until the obvious buy signal in MACD when looking at fast and volatile stocks, you will miss most of the gains. In fast-moving stocks, when looking at the MACD, I think you should look for a clue that there is going to be a buy signal and rely upon other indicators to get in.
Extended breakout or will it continue to run.News on cancer. ir.intelliatx.com
Continued to run after public offering ir.intelliatx.com
Nov started treating in clinical trial. ir.intelliatx.com
Expanded collaboration with regeneron. ir.intelliatx.com
Business Seems to be firing on all cylinders.
Technically looks over extended.
NTLA position initiatedSmall position initiated and wait for pullback to add.
Beta 1.7
Disclaimer, this is only for entertainment and education purposes and doesn't serve by any means as a buy or sell recommendation.
Personally I hold both long term long positions and occasionally short term short position, for disclosure purpose.
$NTLA can rise in the next daysContextual immersion trading strategy idea.
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. It utilizes a biological tool known as the Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system.
The share price rose after the company announced an expansion of its partnership with Regeneron Pharmaceuticals (REGN).
The pair will jointly develop drug candidates to treat hereditary blood disorders hemophilia A and hemophilia B. Additionally, Regeneron Pharmaceuticals will gain rights to develop drug candidates using both in vivo (inside the body) and ex vivo (outside the body) drug candidates and delivery tools developed by Intellia Therapeutics — www.fool.com
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $22,24;
stop-loss — $21,25.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
ntla daily best level to buy 40%/50% upside by projectsyndicateintellia ther daily chart review.
best level to buy for 40-50% gains
update by projectsyndicate
mirror and gap fill level at 12.00
target is S/D zones 17 and 18.50
40/50% gain.
put this on your watchlist
solid setup.
update brought to you by Projectsyndicate.
B barnes group inc D1 short into resistance 25%
box inc daily update by projectsyndicate
hog daily best level to buy for 25% gain projectsyndicate
gwb daily best level to buy 25-30% gain by projectsyndicate
[Idea] NTLA longBreak over long trendline.
Break above rectangle bottoming base, backtested the breakout and the 50ma yesterday.
Human trials are underway
This could really run to the upside and stops are relatively close.
First target: 18.50
I might consider entry if the 15-minute RSI weakens again.